It is a AI-driven Clinical Decision Support System for Ischemic Heart Disease
At the MATRIX 2022, HeARThealth Technologies announced the launch of its ONEcardio Cardiovascular Clinical Decision Support System. ONEcardio is an AI-driven Cardiac MRI analysis and Clinical Decision Support solution for Ischemic Heart Disease. ONEcardio assists cardiovascular radiologists make faster, accurate diagnosis, prognosis and determine the level of risk to the patient’s health. Clinicians can then use this information to determine treatment and to improve patient outcomes.
ONEcardio has been registered with the Indian Medical Device Regulator CDSCO as per the GSR 102 (E) notification dated 11/02/2020 under Medical Devices Rules 2017.
India is experiencing a rapid health transition with a rising burden of Non-Communicable Diseases (NCD) surpassing the burden of Communicable diseases like water-borne or vector borne diseases, TB, HIV, etc. According to the National Health Mission (NHM) of the Ministry of Health and Family Welfare, Government of India, the Non-Communicable Diseases like Cardiovascular diseases, Cancer, Chronic Respiratory Diseases, Diabetes, etc. are estimated to account for around 60% of all deaths. Under this program Cardiac Care Units (CCU) are being set up in identified districts for providing facilities for emergency Cardiac Care. ONEcardio from HeARThealth Technologies’ aims to increase access to high quality cardiac care even in the remotest of locations.
Founded in 2019, HeARThealth Technologies is founded, led and mentored by Clinicians and Technologists with over 100+ years in the HealthTech space globally. HeARThealth Technologies is incubated at DERBI, a Healthtech focused Technology Business Incubator and T-Hub – Atal Innovation Centre and its Lab32 program.